• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 29, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Staphylococcus aureus drives high hospital mortality in infective endocarditis cohort

by
October 29, 2026
in Health
Reading Time: 3 mins read
0
Staphylococcus aureus drives high hospital mortality in infective endocarditis cohort

Staphylococcus aureus drives high hospital mortality in infective endocarditis cohort

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Adults admitted to a tertiary hospital in a middle-income country with definite infective endocarditis died in hospital in nearly one in three cases, according to a retrospective cohort study published in Annals of Clinical Microbiology and Antimicrobials. The analysis, covering admissions between 2011 and 2025, found that infection with Staphylococcus aureus, native-valve endocarditis and increasing age were independently associated with in-hospital death.

The study included 143 adults whose diagnoses met the modified Duke criteria for definite infective endocarditis. The researchers collected demographic, clinical, microbiological, echocardiographic and treatment variables and used multivariable logistic regression to identify independent predictors of in-hospital mortality, reporting effect estimates as adjusted odds ratios with 95% confidence intervals.

In-hospital mortality was 46 of 143 patients, or 32.1%. Blood cultures were positive in 96 of 143 patients (67.1%) and negative in 47 of 143 (32.9%), meaning that nearly one third of cases had no culture confirmation, a substantial culture-negative burden that the authors highlight as a diagnostic challenge in this setting.

Staphylococcus aureus was the leading pathogen identified in the cohort and also showed the highest mortality proportion among the detected organisms, with 16 of 25 patients infected by this bacterium dying in hospital, a mortality proportion of 64.0%.

In the multivariable analysis, S. aureus infection was associated with roughly a sevenfold increase in the odds of in-hospital death (adjusted odds ratio 6.78, 95% CI 2.35–19.58). Native-valve endocarditis was also independently associated with mortality (aOR 3.23, 95% CI 1.06–9.85), as was increasing age, with an adjusted odds ratio of 1.04 per year (95% CI 1.01–1.08).

The authors themselves urge caution in interpreting these adjusted estimates.

Surgical management was a notable gap in the cohort. Surgery was formally indicated in 87 patients, or 60.8% of the cohort, but was performed in 73 patients, or 51.0%, indicating that not all patients with a surgical indication underwent intervention. The study was observational and did not evaluate the effectiveness of the surgical protocol itself; it documented the gap between indication and performance.

The authors conclude that infective endocarditis in this cohort showed high all-cause in-hospital mortality, a substantial culture-negative burden, and a strong prognostic impact of S. aureus. They suggest that strengthening microbiological diagnosis and timely multidisciplinary management may improve outcomes, a statement of planned direction rather than a demonstrated effect of any intervention.

Several limitations should be kept in mind when reading these findings. The study is retrospective and single-center, so its results describe one tertiary referral hospital over 14 years and may not generalize to other settings or to primary-care populations. The article is being shared as an early-access, peer-reviewed accepted version that carries a permanent DOI and remains subject to further editorial edits before the final version of record is published.

Subject of Research: Microbiological profile and in-hospital mortality predictors of infective endocarditis in a tertiary-center cohort from a middle-income country

Article Title: Infective endocarditis in a middle-income country: microbiological profile, culture-negative burden, and in-hospital mortality predictors in a 14-year tertiary-center cohort

Article References: Pavia-Velandia, P. X., Morales-Pertuz, C., León-León, N. G., Garzón-Rodríguez, J. D., Molano-González, N., Rodríguez-Aparicio, E. E., & Rodríguez-Lima, D. R. (2026). Infective endocarditis in a middle-income country: microbiological profile, culture-negative burden, and in-hospital mortality predictors in a 14-year tertiary-center cohort. Annals of Clinical Microbiology and Antimicrobials. https://doi.org/10.1186/s12941-026-00887-y

Image Credits: AI Generated

DOI: 10.1186/s12941-026-00887-y

Keywords: infective endocarditis, Staphylococcus aureus, culture-negative endocarditis, in-hospital mortality, retrospective cohort, modified Duke criteria, native-valve endocarditis, blood cultures, middle-income country, tertiary care, multivariable logistic regression, cardiac surgery

News Source: Ophelia Keating. (October 29, 2026). Staphylococcus aureus drives high hospital mortality in infective endocarditis cohort. Scienmag.

Tags: blood culturesCardiac Surgeryculture-negative endocarditisIn-hospital mortalityinfective endocarditismiddle-income countrymodified Duke criteriamultivariable logistic regressionnative-valve endocarditisRetrospective CohortStaphylococcus aureustertiary care
Share12Tweet7Share2ShareShareShare1

Related Posts

Abrocitinib Sustains Skin Clearance in Moderate and Severe Atopic Dermatitis Through 112 Weeks

Abrocitinib Sustains Skin Clearance in Moderate and Severe Atopic Dermatitis Through 112 Weeks

October 29, 2026
Richer Countries Have Far More Doctors, Dentists and Nurses, Global Analysis Finds

Richer Countries Have Far More Doctors, Dentists and Nurses, Global Analysis Finds

October 29, 2026

Children Prenatally Exposed to Cannabis Show Thinner Cortex in Frontal and Parietal Regions

October 29, 2026

Bone marrow stromal cells drive IL-6 metabolic rewiring and bortezomib resistance in multiple myeloma

October 29, 2026

POPULAR NEWS

  • Structured PLISSIT Counseling Improves Sexual Function in Middle-Aged Women, Trial Finds

    Structured PLISSIT Counseling Improves Sexual Function in Middle-Aged Women, Trial Finds

    29 shares
    Share 12 Tweet 7
  • CarbonBalance Framework Shifts AI Workloads to Cleaner Power, Cutting Simulated Emissions 41.6%

    29 shares
    Share 12 Tweet 7
  • Low Nutritional Risk Means Lower Remimazolam Doses for Sedation in Older Adults

    29 shares
    Share 12 Tweet 7
  • Rising seas could submerge a third of Amsterdam’s cycling network by 2100

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Most mine-safety IoT research stalls at prototype stage, scoping review finds

Abrocitinib Sustains Skin Clearance in Moderate and Severe Atopic Dermatitis Through 112 Weeks

Cellulase improves fermentation of a high-fiber shrub silage in 60-day trial

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.